Device-based brain stimulation to augment fear extinction: Implications for ptsd treatment and beyond

Depression and Anxiety

Volumn 31, Issue 4, 2014, Pages 269-278

  Marin, Marie France ^a,b   Camprodon, Joan A ^a,b   Dougherty, Darin D ^a,b   Milad, Mohammed R ^a,b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

anxiety disorders; DBS; exposure therapy; extinction retention; fear learning; tDCS; TMS; VNS

Indexed keywords

AMYGDALOID NUCLEUS; ANTERIOR CINGULATE; ANXIETY DISORDER; BEHAVIOR THERAPY; BRAIN DEPTH STIMULATION; CONFERENCE PAPER; DEVICE THERAPY; FEAR; HIPPOCAMPUS; HUMAN; INFERIOR FRONTAL GYRUS; LEARNING; MEDICAL TECHNOLOGY; MEMORY; NEUROMODULATION; NEUROSCIENCE; OBSESSIVE COMPULSIVE DISORDER; PATHOPHYSIOLOGY; POSTTRAUMATIC STRESS DISORDER; PRIORITY JOURNAL; REINFORCEMENT; TRANSCRANIAL DIRECT CURRENT STIMULATION; TRANSCRANIAL MAGNETIC STIMULATION; TRANSLATIONAL RESEARCH; VAGUS NERVE STIMULATION; VENTROMEDIAL PREFRONTAL CORTEX; ANIMAL; BRAIN; ELECTROSTIMULATION THERAPY; PHYSIOLOGY; PROCEDURES; RAT;

ANIMALS; BRAIN; DEEP BRAIN STIMULATION; ELECTRIC STIMULATION THERAPY; EXTINCTION, PSYCHOLOGICAL; FEAR; HUMANS; RATS; STRESS DISORDERS, POST-TRAUMATIC; TRANSCRANIAL DIRECT CURRENT STIMULATION; TRANSCRANIAL MAGNETIC STIMULATION; VAGUS NERVE STIMULATION;

EID: 84898833793     PISSN: 10914269     EISSN: 15206394     Source Type: Journal    
DOI: 10.1002/da.22252     Document Type: Conference Paper

References (94)

1. Foa EB,. Prolonged exposure therapy: past, present, and future. Depress Anxiety 2011; 28 (12): 1043-1047.
2. Milad MR, Quirk GJ,. Fear extinction as a model for translational neuroscience: ten years of progress. Annu Rev Psychol 2012; 63: 129-151.
3. Pare D, Duvarci S,. Amygdala microcircuits mediating fear expression and extinction. Curr Opin Neurobiol 2012; 22 (4): 717-723.
4. Martin EI, Ressler KJ, Binder E, Nemeroff CB,. The neurobiology of anxiety disorders: brain imaging, genetics, and psychoneuroendocrinology. Psychiatr Clin North Am 2009; 32 (3): 549-575.
5. LeDoux J,. The emotional brain, fear, and the amygdala. Cell Mol Neurobiol 2003; 23 (4-5): 727-738.
6. Bouton ME, Westbrook RF, Corcoran KA, Maren S,. Contextual and temporal modulation of extinction: behavioral and biological mechanisms. Biol Psychiatry 2006; 60 (4): 352-360.
7. Milad MR, Wright CI, Orr SP, Pitman RK, Quirk GJ, Rauch SL,. Recall of fear extinction in humans activates the ventromedial prefrontal cortex and hippocampus in concert. Biol Psychiatry 2007; 62 (5): 446-454.
8. Rougemont-Bücking A, Linnman C, Zeffiro TA, et al. Altered processing of contextual information during fear extinction in PTSD: an fMRI study. CNS Neurosci Ther 2011; 17 (4): 227-236.
9. Kalisch R, Korenfeld E, Stephan KE, Weiskopf N, Seymour B, Dolan RJ,. Context-dependent human extinction memory is mediated by a ventromedial prefrontal and hippocampal network. J Neurosci 2006; 26 (37): 9503-9511.
10. Linnman C, Zeidan MA, Pitman RK, Milad MR,. Resting cerebral metabolism correlates with skin conductance and functional brain activation during fear conditioning. Biol Psychol 2012; 89 (2): 450-459.
11. Dunsmoor JE, Bandettini PA, Knight DC,. Impact of continuous versus intermittent CS-UCS pairing on human brain activation during Pavlovian fear conditioning. Behav Neurosci 2007; 121 (4): 635-642.
12. Critchley HD, Mathias CJ, Dolan RJ,. Fear conditioning in humans: the influence of awareness and autonomic arousal on functional neuroanatomy. Neuron 2002; 33 (4): 653-663.
13. Büchel C, Morris J, Dolan RJ, Friston KJ,. Brain systems mediating aversive conditioning: an event-related fMRI study. Neuron 1998; 20 (5): 947-957.
14. Mueller D, Porter JT, Quirk GJ,. Noradrenergic signaling in infralimbic cortex increases cell excitability and strengthens memory for fear extinction. J Neurosci 2008; 28 (2): 369-375.
15. Milad MR, Quirk GJ,. Neurons in medial prefrontal cortex signal memory for fear extinction. Nature 2002; 420 (6911): 70-74.
16. Milad MR, Rauch SL, Pitman RK, Quirk GJ,. Fear extinction in rats: implications for human brain imaging and anxiety disorders. Biol Psychol 2006; 73 (1): 61-71.
17. Burgos-Robles A, Vidal-Gonzalez I, Santini E, Quirk GJ,. Consolidation of fear extinction requires NMDA receptor-dependent bursting in the ventromedial prefrontal cortex. Neuron 2007; 53 (6): 871-880.
18. Burgos-Robles A, Vidal-Gonzalez I, Quirk GJ,. Sustained conditioned responses in prelimbic prefrontal neurons are correlated with fear expression and extinction failure. J Neurosci 2009; 29 (26): 8474-8482.
19. Lebrõn K, Milad MR, Quirk GJ,. Delayed recall of fear extinction in rats with lesions of ventral medial prefrontal cortex. Learn Mem 2004; 11 (5): 544-548.
20. Sierra-Mercado D Jr, Corcoran KA, Lebrõn-Milad K, Quirk GJ,. Inactivation of the ventromedial prefrontal cortex reduces expression of conditioned fear and impairs subsequent recall of extinction. Eur J Neurosci 2006; 24 (6): 1751-1758.
21. Pitman RK, Rasmusson A, Koenen KC, et al. Biological studies of post-traumatic stress disorder. Nat Rev Neurosci 2012; 13 (11): 769-787.
22. Milad MR, Quirk GJ, Pitman RK, Orr SP, Fischl B, Rauch SL,. A role for the human dorsal anterior cingulate cortex in fear expression. Biol Psychiatry 2007; 62 (10): 1191-1194.
23. Milad MR, Quinn BT, Pitman RK, Orr SP, Fischl B, Rauch SL,. Thickness of ventromedial prefrontal cortex in humans is correlated with extinction memory. Proc Natl Acad Sci USA 2005; 102 (30): 10706-10711.
24. Hartley CA, Fischl B, Phelps EA,. Brain structure correlates of individual differences in the acquisition and inhibition of conditioned fear. Cereb Cortex 2011; 21 (9): 1954-1962.
25. Phelps EA, Delgado MR, Nearing KI, LeDoux JE,. Extinction learning in humans: role of the amygdala and vmPFC. Neuron 2004; 43 (6): 897-905.
26. Cheng DT, Knight DC, Smith CN, Stein EA, Helmstetter FJ,. Functional MRI of human amygdala activity during Pavlovian fear conditioning: stimulus processing versus response expression. Behav Neurosci 2003; 117 (1): 3-10.
27. Knight DC, Smith CN, Cheng DT, Stein EA, Helmstetter FJ,. Amygdala and hippocampal activity during acquisition and extinction of human fear conditioning. Cogn Affect Behav Neurosci 2004; 4 (3): 317-325.
28. LaBar KS, Gatenby JC, Gore JC, LeDoux JE, Phelps EA,. Human amygdala activation during conditioned fear acquisition and extinction: a mixed-trial fMRI study. Neuron 1998; 20 (5): 937-945.
29. Rauch SL, Shin LM, Phelps EA,. Neurocircuitry models of posttraumatic stress disorder and extinction: human neuroimaging research-past, present, and future. Biol Psychiatry 2006; 60 (4): 376-382.
30. Maren S, Phan KL, Liberzon I,. The contextual brain: implications for fear conditioning, extinction and psychopathology. Nat Rev Neurosci 2013; 14 (6): 417-428.
31. Orr SP, Metzger LJ, Lasko NB, Macklin ML, Peri T, Pitman RK,. De novo conditioning in trauma-exposed individuals with and without posttraumatic stress disorder. J Abnorm Psychol 2000; 109 (2): 290-298.
32. Peri T, Ben-Shakhar G, Orr SP, Shalev AY,. Psychophysiologic assessment of aversive conditioning in posttraumatic stress disorder. Biol Psychiatry 2000; 47 (6): 512-519.
33. Milad MR, Orr SP, Lasko NB, Chang Y, Rauch SL, Pitman RK,. Presence and acquired origin of reduced recall for fear extinction in PTSD: results of a twin study. J Psychiatr Res 2008; 42 (7): 515-520.
34. Milad MR, Pitman RK, Ellis CB, et al. Neurobiological basis of failure to recall extinction memory in posttraumatic stress disorder. Biol Psychiatry 2009; 66 (12): 1075-1082.
35. Gilbertson MW, Shenton ME, Ciszewski A, et al. Smaller hippocampal volume predicts pathologic vulnerability to psychological trauma. Nat Neurosci 2002; 5 (11): 1242-1247.
36. Bremner JD, Randall P, Scott TM, et al. MRI-based measurement of hippocampal volume in patients with combat-related posttraumatic stress disorder. Am J Psychiatry 1995; 152 (7): 973-981.
37. Gurvits TV, Shenton ME, Hokama H, et al. Magnetic resonance imaging study of hippocampal volume in chronic, combat-related posttraumatic stress disorder. Biol Psychiatry 1996; 40 (11): 1091-1099.
38. Stein MB, Koverola C, Hanna C, Torchia MG, McClarty B,. Hippocampal volume in women victimized by childhood sexual abuse. Psychol Med 1997; 27 (4): 951-959.
39. Kitayama N, Quinn S, Bremner JD,. Smaller volume of anterior cingulate cortex in abuse-related posttraumatic stress disorder. J Affect Disord 2006; 90 (2-3): 171-174.
40. Kasai K, Yamasue H, Gilbertson MW, Shenton ME, Rauch SL, Pitman RK,. Evidence for acquired pregenual anterior cingulate gray matter loss from a twin study of combat-related posttraumatic stress disorder. Biol Psychiatry 2008; 63 (6): 550-556.
41. Rauch SL, Shin LM, Segal E, et al. Selectively reduced regional cortical volumes in post-traumatic stress disorder. Neuroreport 2003; 14 (7): 913-916.
42. Shin LM, Liberzon I,. The neurocircuitry of fear, stress, and anxiety disorders. Neuropsychopharmacology 2010; 35 (1): 169-191.
43. Liberzon I, Phan KL,. Brain-imaging studies of posttraumatic stress disorder. CNS Spectrums 2003; 8 (9): 641-650.
44. Etkin A, Wager TD,. Functional neuroimaging of anxiety: a meta-analysis of emotional processing in PTSD, social anxiety disorder, and specific phobia. Am J Psychiatry 2007; 164 (10): 1476-1488.
45. Bremner JD, Vythilingam M, Vermetten E, et al. MRI and PET study of deficits in hippocampal structure and function in women with childhood sexual abuse and posttraumatic stress disorder. Am J Psychiatry 2003; 160 (5): 924-932.
46. Ressler KJ, Rothbaum BO, Tannenbaum L, et al. Cognitive enhancers as adjuncts to psychotherapy: use of D-cycloserine in phobic individuals to facilitate extinction of fear. Arch Gen Psychiatry 2004; 61 (11): 1136-1144.
47. Norberg MM, Krystal JH, Tolin DF,. A meta-analysis of D-cycloserine and the facilitation of fear extinction and exposure therapy. Biol Psychiatry 2008; 63 (12): 1118-1126.
48. Brunet A, Orr SP, Tremblay J, Robertson K, Nader K, Pitman RK,. Effect of post-retrieval propranolol on psychophysiologic responding during subsequent script-driven traumatic imagery in post-traumatic stress disorder. J Psychiatr Res 2008; 42 (6): 503-506.
49. Kindt M, Soeter M, Vervliet B,. Beyond extinction: erasing human fear responses and preventing the return of fear. Nat Neurosci 2009; 12 (3): 256-258.
50. Schiller D, Monfils M-H, Raio CM, Johnson DC, Ledoux JE, Phelps EA,. Preventing the return of fear in humans using reconsolidation update mechanisms. Nature 2010; 463 (7277): 49-53.
51. Dougherty DD, Rauch SL,. Somatic therapies for treatment-resistant depression: new neurotherapeutic interventions. Psychiatr Clin North Am 2007;3 0 (1): 31-37.
52. Rodman AM, Milad MR, Deckersbach T, Im J, Chou T, Dougherty DD,. Neuroimaging contributions to novel surgical treatments for intractable obsessive-compulsive disorder. Expert Rev Neurother 2012; 12 (2): 219-227.
53. Fecteau S, Fregni F, Boggio PS, Camprodon JA, Pascual-Leone A,. Neuromodulation of decision-making in the addictive brain. Subst Use Misuse 2010; 45 (11): 1766-1786.
54. Camprodon JA, Martínez-Raga J, Alonso-Alonso M, Shih M-C, Pascual-Leone A,. One session of high frequency repetitive transcranial magnetic stimulation (rTMS) to the right prefrontal cortex transiently reduces cocaine craving. Drug Alcohol Depend 2007; 86 (1): 91-94.
55. Rauch SL, Dougherty DD, Malone D, et al. A functional neuroimaging investigation of deep brain stimulation in patients with obsessive-compulsive disorder. J Neurosurg 2006; 104 (4): 558-565.
56. Rosa M, Giannicola G, Marceglia S, Fumagalli M, Barbieri S, Priori A,. Neurophysiology of deep brain stimulation. Int Rev Neurobiol 2012; 107: 23-55.
57. Yu H, Neimat JS,. The treatment of movement disorders by deep brain stimulation. Neurother J Am Soc Exp Neurother 2008; 5 (1): 26-36.
58. Gross RE, Lozano AM,. Advances in neurostimulation for movement disorders. Neurol Res 2000; 22 (3): 247-258.
59. Mayberg HS, Lozano AM, Voon V, et al. Deep brain stimulation for treatment-resistant depression. Neuron 2005; 45 (5): 651-660.
60. Mian MK, Campos M, Sheth SA, Eskandar EN,. Deep brain stimulation for obsessive-compulsive disorder: past, present, and future. Neurosurg Focus 2010; 29 (2): E10.
61. Puigdemont D, Pérez-Egea R, Portella MJ, et al. Deep brain stimulation of the subcallosal cingulate gyrus: further evidence in treatment-resistant major depression. Int J Neuropsychopharmacol 2011; 15: 1-13.
62. Denys D, Mantione M, Figee M, et al. Deep brain stimulation of the nucleus accumbens for treatment-refractory obsessive-compulsive disorder. Arch Gen Psychiatry 2010; 67 (10): 1061-1068.
63. Rodriguez-Romaguera J, Do Monte FHM, Quirk GJ,. Deep brain stimulation of the ventral striatum enhances extinction of conditioned fear. Proc Natl Acad Sci USA 2012; 109 (22): 8764-8769.
64. Do-Monte FH, Rodriguez-Romaguera J, Rosas-Vidal LE, Quirk GJ,. Deep brain stimulation of the ventral striatum increases BDNF in the fear extinction circuit. Front Behav Neurosci 2013; 7: 1-9.
65. George MS, Sackeim HA, Rush AJ, et al. Vagus nerve stimulation: a new tool for brain research and therapy. Biol Psychiatry 2000; 47 (4): 287-295.
66. McGaugh JL, Cahill L, Roozendaal B,. Involvement of the amygdala in memory storage: interaction with other brain systems. Proc Natl Acad Sci USA 1996; 93 (24): 13508-13514.
67. McGaugh JL, McIntyre CK, Power AE,. Amygdala modulation of memory consolidation: interaction with other brain systems. Neurobiol Learn Mem 2002; 78 (3): 539-552.
68. McGaugh JL, Roozendaal B,. Role of adrenal stress hormones in forming lasting memories in the brain. Curr Opin Neurobiol 2002; 12 (2): 205-210.
69. Berlau DJ, McGaugh JL,. Enhancement of extinction memory consolidation: the role of the noradrenergic and GABAergic systems within the basolateral amygdala. Neurobiol Learn Mem 2006; 86 (2): 123-132.
70. Cain CK, Blouin AM, Barad M,. Adrenergic transmission facilitates extinction of conditional fear in mice. Learn Mem 2004; 11 (2): 179-187.
71. Peña DF, Engineer ND, McIntyre CK,. Rapid remission of conditioned fear expression with extinction training paired with vagus nerve stimulation. Biol Psychiatry 2013; 73 (11): 1071-1077.
72. Fanselow MS,. Fear and anxiety take a double hit from vagal nerve stimulation. Biol Psychiatry 2013; 73 (11): 1043-1044.
73. Paulus W,. Transcranial direct current stimulation (tDCS). Suppl Clin Neurophysiol 2003; 56: 249-254.
74. Nitsche MA, Fricke K, Henschke U, et al. Pharmacological modulation of cortical excitability shifts induced by transcranial direct current stimulation in humans. J Physiol 2003; 553 (Pt 1): 293-301.
75. Kuo M-F, Paulus W, Nitsche MA,. Therapeutic effects of non-invasive brain stimulation with direct currents (tDCS) in neuropsychiatric diseases. Neuroimage 2013; 85 (Pt 3): 948-960.
76. Coffman BA, Clark VP, Parasuraman R,. Battery powered thought: enhancement of attention, learning, and memory in healthy adults using transcranial direct current stimulation. Neuroimage 2013; 85 (Pt 3): 895-908.
77. Vallar G, Bolognini N,. Behavioural facilitation following brain stimulation: implications for neurorehabilitation. Neuropsychol Rehabil 2011; 21 (5): 618-649.
78. Penolazzi B, Di Domenico A, Marzoli D, et al. Effects of transcranial direct current stimulation on episodic memory related to emotional visual stimuli. PloS One 2010; 5 (5): e10623.
79. Asthana M, Nueckel K, Mühlberger A, et al. Effects of transcranial direct current stimulation on consolidation of fear memory. Front Psychiatry 2013; 4: 1-7.
80. Brunoni AR, Valiengo L, Baccaro A, et al. The sertraline vs. electrical current therapy for treating depression clinical study: results from a factorial, randomized, controlled trial. JAMA Psychiatry 2013; 70 (4): 383-391.
81. Rossi S, Hallett M, Rossini PM, Pascual-Leone A,. Safety of TMS Consensus Group. Safety, ethical considerations, and application guidelines for the use of transcranial magnetic stimulation in clinical practice and research. Clin Neurophysiol 2009; 120 (12): 2008-2039.
82. O'Reardon JP, Solvason HB, Janicak PG, et al. Efficacy and safety of transcranial magnetic stimulation in the acute treatment of major depression: a multisite randomized controlled trial. Biol Psychiatry 2007; 62 (11): 1208-1216.
83. Bersani FS, Minichino A, Enticott PG, et al. Deep transcranial magnetic stimulation as a treatment for psychiatric disorders: a comprehensive review. Eur Psychiatry 2013; 28 (1): 30-39.
84. Pascual-Leone A, Tormos JM, Keenan J, Tarazona F, Cañete C, Catalá MD,. Study and modulation of human cortical excitability with transcranial magnetic stimulation. J Clin Neurophysiol 1998; 15 (4): 333-343.
85. Hugues S, Deschaux O, Garcia R,. Postextinction infusion of a mitogen-activated protein kinase inhibitor into the medial prefrontal cortex impairs memory of the extinction of conditioned fear. Learn Mem 2004; 11 (5): 540-543.
86. Farinelli M, Deschaux O, Hugues S, Thevenet A, Garcia R,. Hippocampal train stimulation modulates recall of fear extinction independently of prefrontal cortex synaptic plasticity and lesions. Learn Mem 2006; 13 (3): 329-334.
87. Herry C, Garcia R,. Prefrontal cortex long-term potentiation, but not long-term depression, is associated with the maintenance of extinction of learned fear in mice. J Neurosci 2002; 22 (2): 577-583.
88. Vidal-Gonzalez I, Vidal-Gonzalez B, Rauch SL, Quirk GJ,. Microstimulation reveals opposing influences of prelimbic and infralimbic cortex on the expression of conditioned fear. Learn Mem 2006; 13 (6): 728-733.
89. Delgado MR, Nearing KI, Ledoux JE, Phelps EA,. Neural circuitry underlying the regulation of conditioned fear and its relation to extinction. Neuron 2008; 59 (5): 829-838.
90. Osuch EA, Benson BE, Luckenbaugh DA, Geraci M, Post RM, McCann U,. Repetitive TMS combined with exposure therapy for PTSD: a preliminary study. J Anxiety Disord 2009; 23 (1): 54-59.
91. Boggio PS, Rocha M, Oliveira MO, et al. Noninvasive brain stimulation with high-frequency and low-intensity repetitive transcranial magnetic stimulation treatment for posttraumatic stress disorder. J Clin Psychiatry 2010; 71 (8): 992-999.
92. Ji G, Neugebauer V,. Modulation of medial prefrontal cortical activity using in vivo recordings and optogenetics. Mol Brain 2012; 5 (36): 1-10.
93. Sinha R, Li CSR,. Imaging stress- and cue-induced drug and alcohol craving: association with relapse and clinical implications. Drug Alcohol Rev 2007; 26 (1): 25-31.
94. Klavir O, Genud-Gabai R, Paz R,. Low-frequency stimulation depresses the primate anterior-cingulate-cortex and prevents spontaneous recovery of aversive memories. J Neurosci 2012; 32 (25): 8589-8597.